Skip to content

Bohai Pharmaceuticals Group, Inc.: 10-Q filed 2014-02-14

What Bohai Pharmaceuticals Group, Inc. reported in its quarterly report filed 2014-02-14 (fiscal Q2 2014): 43 published measures, 128 facts as tagged in accession 0001144204-14-009269.

This filing

Form
10-Q (quarterly report)
Filed
2014-02-14
Fiscal period
fiscal Q2 2014
Accession
0001144204-14-009269 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All Bohai Pharmaceuticals Group, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2013-12-31173,025,933USD
At 2013-06-30165,624,398USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2013-12-3149,274,081USD
At 2013-06-3057,234,844USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2013-12-31123,751,852USD
At 2013-06-30108,389,554USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2013-12-316,386,084USD
At 2013-06-306,947,972USD
At 2012-12-313,154,584USD
At 2012-06-3018,386,288USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2013-10-01 to 2013-12-316,009,031USD92
2013-07-01 to 2013-12-3114,096,762USD184
2012-10-01 to 2012-12-315,258,737USD92
2012-07-01 to 2012-12-3111,654,249USD184

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2013-07-01 to 2013-12-31182,117USD184
2012-07-01 to 2012-12-31433,131USD184

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2013-12-3188,853,521USD
At 2013-06-3074,756,759USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2013-10-01 to 2013-12-3117,861,085shares92
2013-07-01 to 2013-12-3117,861,085shares184
2012-10-01 to 2012-12-3117,861,085shares92
2012-07-01 to 2012-12-3117,861,085shares184

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2013-10-01 to 2013-12-3121,945,509shares92
2013-07-01 to 2013-12-3122,019,422shares184
2012-10-01 to 2012-12-3122,093,335shares92
2012-07-01 to 2012-12-3122,093,335shares184

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2013-10-01 to 2013-12-310.34USD/shares92
2013-07-01 to 2013-12-310.79USD/shares184
2012-10-01 to 2012-12-310.29USD/shares92
2012-07-01 to 2012-12-310.65USD/shares184

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2013-10-01 to 2013-12-310.28USD/shares92
2013-07-01 to 2013-12-310.66USD/shares184
2012-10-01 to 2012-12-310.25USD/shares92
2012-07-01 to 2012-12-310.55USD/shares184

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2013-10-01 to 2013-12-312,105,526USD92
2013-07-01 to 2013-12-314,859,539USD184
2012-10-01 to 2012-12-311,758,578USD92
2012-07-01 to 2012-12-313,939,824USD184

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2013-12-3117,660,903USD
At 2013-06-3017,678,453USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2013-10-01 to 2013-12-318,904,452USD92
2013-07-01 to 2013-12-3120,131,809USD184
2012-10-01 to 2012-12-316,721,748USD92
2012-07-01 to 2012-12-3115,312,458USD184

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2013-12-3170,474,840USD
At 2013-06-3061,519,011USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2013-10-01 to 2013-12-31856,642USD92
2013-07-01 to 2013-12-311,218,928USD184
2012-10-01 to 2012-12-31426,323USD92
2012-07-01 to 2012-12-31939,356USD184

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2013-12-3141,175,834USD
At 2013-06-3044,186,731USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2013-12-314,684,494USD
At 2013-06-305,081,913USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2013-12-3132,153,295CNY
At 2013-06-3032,153,295CNY
At 2013-12-315,262,061USD
At 2013-06-305,202,209USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2013-12-3137,881,530USD
At 2013-06-3037,863,464USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2013-12-3145,889,957USD
At 2013-06-3038,716,023USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2013-10-01 to 2013-12-3120,722,712USD92
2013-07-01 to 2013-12-3148,676,761USD184
2012-10-01 to 2012-12-3124,927,109USD92
2012-07-01 to 2012-12-3142,790,330USD184

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2013-12-315,042,661USD
At 2013-06-302,781,734USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2013-10-01 to 2013-12-3129,627,164USD92
2013-07-01 to 2013-12-3168,808,570USD184
2012-10-01 to 2012-12-3131,648,857USD92
2012-07-01 to 2012-12-3158,102,788USD184

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2013-10-01 to 2013-12-3120,003,910USD92
2013-07-01 to 2013-12-3147,244,399USD184
2012-10-01 to 2012-12-3122,546,807USD92
2012-07-01 to 2012-12-3139,753,923USD184

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2013-10-01 to 2013-12-3123,705USD92
2013-07-01 to 2013-12-3162,751USD184
2012-10-01 to 2012-12-311,995USD92
2012-07-01 to 2012-12-313,990USD184

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2013-12-3117,861,085shares
At 2013-06-3017,861,085shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2013-12-3110,265,117USD
At 2013-06-308,999,581USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2013-12-3118,627,327USD
At 2013-06-3018,212,322USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2013-12-313,405,853USD
At 2013-06-302,827,442USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2013-12-3111,037,264USD
At 2013-06-3012,185,615USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2013-12-31437,453USD
At 2013-06-30499,231USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2013-10-01 to 2013-12-318,114,557USD92
2013-07-01 to 2013-12-3118,956,301USD184
2012-10-01 to 2012-12-317,017,315USD92
2012-07-01 to 2012-12-3115,594,073USD184

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2013-10-01 to 2013-12-316,649,929USD92
2013-07-01 to 2013-12-3115,362,298USD184
2012-10-01 to 2012-12-315,711,767USD92
2012-07-01 to 2012-12-3111,858,332USD184

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2013-10-01 to 2013-12-316,009,031USD92
2013-07-01 to 2013-12-3114,096,762USD184
2012-10-01 to 2012-12-315,258,737USD92
2012-07-01 to 2012-12-3111,654,249USD184

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2013-10-01 to 2013-12-31278,830USD92
2013-07-01 to 2013-12-31555,578USD184
2012-10-01 to 2012-12-31144,367USD92
2012-07-01 to 2012-12-31287,490USD184

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2013-10-01 to 2013-12-31718,802USD92
2013-07-01 to 2013-12-311,432,362USD184
2012-10-01 to 2012-12-31691,816USD92
2012-07-01 to 2012-12-311,347,921USD184

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2013-10-01 to 2013-12-31-5,183USD92
2013-07-01 to 2013-12-31-31,300USD184
2012-10-01 to 2012-12-31115USD92
2012-07-01 to 2012-12-31-16,591USD184

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2013-10-01 to 2013-12-31-789,895USD92
2013-07-01 to 2013-12-31-1,175,508USD184
2012-10-01 to 2012-12-31295,567USD92
2012-07-01 to 2012-12-31281,615USD184

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2013-07-01 to 2013-12-31-42,239USD184
2012-07-01 to 2012-12-31-323,476USD184

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2013-07-01 to 2013-12-316,693,563USD184
2012-07-01 to 2012-12-3113,168,118USD184

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2013-07-01 to 2013-12-312,217,346USD184
2012-07-01 to 2012-12-31-519,251USD184

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2013-07-01 to 2013-12-31-453,519USD184
2012-07-01 to 2012-12-31275,229USD184

Inspect the source

Entity
Bohai Pharmaceuticals Group, Inc. / CIK 0001443242
Captured
SEC response SHA-256
231cd66af3d2b49ce2aa3d470fecf13855af56710429934b8f03d791fb54b2d8

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001443242.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))